The Hirshberg Foundation is excited to have Anirban Maitra, MBBS, joining us at the 13th Annual Symposium on Pancreatic Cancer to share important information about the challenges of treating this cancer and the best way forward to make a difference in patient outcomes.
Anirban Maitra, MBBS, is Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, and has been the Scientific Director of the Sheikh Ahmed Center for Pancreatic Cancer Research since August 1, 2013. Over the past decade, his group has made several seminal observations in the biology and genetics of pancreatic cancer. He also has extensive expertise with genetic modeling of pancreatic cancer and with experimental therapeutics and drug development for this disease. Dr. Maitra brought to Houston his passion for improving patient survival by discovering and developing ways to detect and treat pancreatic cancer.
“We need to remember that what we do in the lab needs to end up in patients. It’s not about an elegant experiment and an excellent scientific publication — it’s all about translation, translation, translation [to humans]” Dr. Maitra stresses. In his presentation at the 13th Annual Symposium, Dr. Maitra speak on Why is Pancreatic Cancer so Hard to Treat and what can we do about it?
